Article
Inhaled nitric oxide use in COVID19-induced hypoxemic respiratory failure
2021-08-21
Abstract excerpt
<h4>Introduction</h4> Nitric Oxide (NO) is an endogenous vasodilator that is synthesized by the vascular endothelium. Due to its vasodilatory effect and short half-life, the use of NO as an exogenous inhaled medication (iNO) to target the pulmonary vasculature, in conditions with increased pulmonary vascular resistance, has been studied. The use of iNO in patients with ARDS secondary to COVID-19 has therapeutic im...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2af65c9a-3e9d-595b-97bf-4972f47e7d51
- DOI
- 10.1101/2021.08.19.21262314
